Partnering Senseonics with Sequel to utilize a one-year Continuous Glucose Monitoring system in an automated insulin dosing setup.
Senseonics, a leading manufacturer of continuous glucose monitoring (CGM) systems, is partnering with Sequel Med Tech to integrate its Eversense 365 implantable CGM with the Twiist automated insulin delivery (AID) system. This collaboration marks a significant step towards combining long-term implantable CGM technology with automated insulin delivery.
The partnership extends the compatibility of Sequel's Twiist system to allow people with Type 1 diabetes to use Senseonics' Eversense 365 CGM. The Food and Drug Administration cleared Eversense 365 as an integrated CGM in September, paving the way for this collaboration. Sequel has also partnered with Abbott to integrate Twiist with the Freestyle Libre 3 Plus Sensor.
Senseonics' Eversense 365 offers a unique extended one-year sensor life, reducing the need for frequent sensor replacements. This could benefit AID system users by providing stable and long-term glucose monitoring data. However, broader details on other pump partners currently in collaboration or future plans to expand partnerships beyond Sequel Med Tech have not been disclosed.
Mukul Jain, Senseonics' COO, expressed the importance of compatibility with multiple CGM and pump systems due to patients' potential changes. He stated that the team has passed prototyping with potential pump partners in a couple of instances. Jain also expressed hope to discuss public integrations with pump partners in the coming quarters.
Senseonics remains focused on growth following the U.S. launch of Eversense 365 and continues product innovation with upcoming devices like Gemini and Freedom. The company is financially positioning itself through stock offerings and partnerships, such as one with Abbott Laboratories, potentially supporting these integrations and expansions.
The companies plan to launch the system in the third quarter, with Twiist set to launch commercially in the U.S. in the second quarter. Twiist uses an AID app developed by the nonprofit Tidepool. Deka Research & Development, Sequel's partner, received 510(k) clearance for Twiist in March 2024.
This collaboration between Senseonics and Sequel Med Tech is a significant step forward in the field of diabetes management, aiming to provide patients with a more convenient and reliable long-term CGM and automated insulin delivery solution.
- In the realm of diabetes management, Senseonics has collaborated with Sequel Med Tech, a move significant for integrating Eversense 365 with the Twiist AID system.
- The combination of long-term implantable CGM technology with automated insulin delivery is a significant stride made by this collaboration.
- Sequel's Twiist system now accommodates Senseonics' Eversense 365 CGM, offering a compatible solution for Type 1 diabetes management.
- The FDA cleared Eversense 365 as an integrated CGM in September, facilitating this collaboration.
- Sequel has also partnered with Abbott to integrate Twiist with the Freestyle Libre 3 Plus Sensor.
- Senseonics' Eversense 365 boasts a unique extended one-year sensor life, reducing the need for frequent sensor replacements.
- This extended life could benefit AID system users by providing stable and long-term glucose monitoring data.
- Mukul Jain, Senseonics' COO, highlighted the importance of compatibility with multiple CGM and pump systems to cater to potential patient changes.
- Jain stated that prototyping with potential pump partners has already been completed in a couple of instances.
- Jain expressed hope for future public discussions with pump partners about integrations in the coming quarters.
- Senseonics is committed to growth, with the U.S. launch of Eversense 365 and upcoming devices like Gemini and Freedom.
- The company is financially positioning itself through stock offerings and partnerships, like the one with Abbott Laboratories, to support integrations and expansions.
- The collaboration aims to launch the system in the third quarter, with Twiist set to debut commercially in the U.S. in the second quarter.
- Twiist employs an AID app developed by the nonprofit Tidepool.
- Deka Research & Development, Sequel's partner, received 510(k) clearance for Twiist in March 2024.
- This collaboration's goal is to deliver a more convenient and reliable long-term CGM and automated insulin delivery solution to patients.
- The field of analytics, particularly in the medical industry, benefits from such technological advancements in diabetes management.
- M&A in the medtech sector has been growing, as companies strive to improve patient care and expand their product offerings.
- Research continues to explore applications of artificial intelligence (AI) in the medical field, including complex diseases like cancer and chronic kidney disease.
- AI is also crucial in tracking news related to medical conditions, helping patients and healthcare providers stay informed.
- To encourage a healthy and active lifestyle, it's essential to focus on fitness and exercise, along with a balanced diet for those with chronic diseases like respiratory conditions, digestive health issues, or eye-health concerns.
- Hearing health is vital, with many conditions affecting people of all ages, making it crucial to prioritize regular check-ups and appropriate treatment.
- Health and wellness go beyond physical fitness; mental health, relationships, and psychological well-being are equally important aspects to address.
- Climate change affects various aspects of health, including cardiovascular health, autoimmune disorders, and skin conditions.
- The manufacturing industry should prioritize sustainability in response to growing concerns about environmental issues and climate change.
- Proper nutrition plays a vital role in managing and preventing chronic diseases, supporting the food and beverage industry's development of healthier options.
- The retail sector can contribute to healthier lifestyles by offering options that cater to environmental concerns and promote sustainable living.
- Fashion and beauty products must ensure safety and effectiveness, considering their direct impact on skin, eye, and hearing health.
- The interior design and cooking sectors can promote healthy living by advocating for eco-friendly materials and products, as well as educating people on nutritious cooking methods and global cuisines.
- For managing wealth, investing in stocks, real estate, or private equity requires understanding financial news, trends, and strategies, such as those found in fintech, venture capital, personal finance, and wealth management sectors.
